Inventor · disambiguated record
Joshua Odingo
Also filed as: ODINGO JOSHUA · ODINGO JOSHUA O
19 granted patents·14 pending applications·371 citations·filing 1999–2025
95Inventor score
Top patents by PatentIndex Score
33 records- 0194US6423710B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2000·Granted Jul 23, 2002·47 cites·27 claims
- 0293US6348602B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2000·Granted Feb 19, 2002·49 cites·33 claims
- 0391US6486186B2Thiazole compounds as cyclic AMP-specific phosphodiesterase inhibitors and method of using the sameICOS CORP·Filed 2001·Granted Nov 26, 2002·43 cites·5 claims
- 0489US9034864B2Azetidinyloxyphenylpyrrolidine compoundsLILLY CO ELI·Filed 2014·Granted May 19, 2015·9 cites·6 claims
- 0589US6458787B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2001·Granted Oct 1, 2002·24 cites·22 claims
- 0688US6258833B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 1999·Granted Jul 10, 2001·55 cites·37 claims
- 0787US6680336B2Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2002·Granted Jan 20, 2004·23 cites·4 claims
- 0886US6294561B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2000·Granted Sep 25, 2001·22 cites·37 claims
- 0985US6500856B2Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2001·Granted Dec 31, 2002·20 cites·4 claims
- 1085US6313156B1Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2000·Granted Nov 6, 2001·20 cites·35 claims
- 1184US11827619B2Dichlorophenol HSD17B13 inhibitors and uses thereofINIPHARM INC·Filed 2023·Granted Nov 28, 2023·1 cites·28 claims
- 1284US9604967B2Azetidinyloxyphenylpyrrolidine compoundsLILLY CO ELI·Filed 2016·Granted Mar 28, 2017·3 cites·4 claims
- 1384US6716871B2Cyclic AMP-specific phosphodie sterase inhibitorsICOS CORP·Filed 2002·Granted Apr 6, 2004·14 cites·5 claims
- 1484US6455562B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2001·Granted Sep 24, 2002·18 cites·5 claims
- 1584US6376489B1Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2000·Granted Apr 23, 2002·22 cites·45 claims
- 1671US12227489B2Dichlorophenol HSD17B13 inhibitors and uses thereofINIPHARM INC·Filed 2023·Granted Feb 18, 2025·0 cites·28 claims
- 1767US2023183239A1Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) inhibitors and uses thereofABBVIE INC·Filed 2022·Application pending·0 cites
- 1866US6998416B2Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2004·Granted Feb 14, 2006·1 cites·2 claims
- 1960US7176229B2Cyclic AMP-specific phosphodiesterase inhibitorsICOS CORP·Filed 2005·Granted Feb 13, 2007·0 cites·7 claims
- 2060US2025376457A1Dichlorophenol hsd17b13 inhibitors and uses thereofINIPHARM INC·Filed 2025·Application pending·0 cites
- 2155US2025320186A1Hsd17b13 inhibitors and uses thereofINIPHARM INC·Filed 2023·Application pending·0 cites
- 2255US2020291024A1Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) inhibitors and uses thereofABBVIE INC·Filed 2018·Application pending·0 cites
- 2354US10781202B2Azetidinyloxyphenylpyrrolidine compoundsLILLY CO ELI·Filed 2015·Granted Sep 22, 2020·0 cites·10 claims
- 2454US2025100993A12-substituted thiazole hsd17b13 inhibitors and uses thereofINIPHARM INC·Filed 2023·Application pending·0 cites
- 2552US2020002318A1Azetidinyloxyphenylpyrrolidine compoundsLILLY CO ELI·Filed 2019·Application pending·0 cites
- 2650US2024208929A1Hydroxypyridine hsd17b13 inhibitors and uses thereofINIPHARM INC·Filed 2022·Application pending·0 cites
- 2750US2024208959A1Thiazole/isothiazole hsd17b13 inhibitors and uses thereofINIPHARM INC·Filed 2022·Application pending·0 cites
- 2849US2023416802A1Specific substrates and products of hsd17b13 as markers of liver disease and biomarkers for liver disease treatmentINIPHARM INC·Filed 2021·Application pending·0 cites
- 2947US2023286923A1Quinazolinone hsd17b13 inhibitors and uses thereofINIPHARM INC·Filed 2021·Application pending·0 cites
- 3047US2023278978A1Thiophene hsd17b13 inhibitors and uses thereofINIPHARM INC·Filed 2021·Application pending·0 cites
- 3145US2023150940A1Hsd17b13 inhibitors and uses thereofINIPHARM INC·Filed 2021·Application pending·0 cites
- 3245US2019282703A1Ectonucleotide pyrophosphatase-phosphodiesterase (enpp) conjugates and uses thereofMAVUPHARMA INC·Filed 2018·Application pending·0 cites
- 3343US2021023234A1Ectonucleotide pyrophosphate-phosphodiesterase (enpp) conjugates and uses thereofABBVIE INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joshua Odingo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →